The N-MOmentum pivotal trial (NCT02200770) is the largest phase 3 clinical trial in NMOSD and the only phase 3 trial that collected MRI data, which was incorporated into its attack adjudication ...
Roche is two for two in its phase 3 trials programme for satralizumab in the rare disease neuromyelitis optica spectrum disorder (NMOSD), setting up regulatory filings. The interleukin-6-targeting ...
A team of researchers from Germany demonstrated that aquaporin 4 (AQP4)-specific T cells dictate the localization of neuromyelitis optica spectrum disorder (NMOSD) lesions in the central nervous ...
Current disability scores fall short of having sufficient NMOSD-specific domains to characterize and predict disability progression. In disorders such as neuromyelitis optica spectrum disorder (NMOSD) ...
Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.
3 Preparation of RM specification/ Brought out items. (FRP/Steel/Theme/Consumables/ Accessories.etc) QA/QC Annual 4 Preparation of Process sheet for FRP Production HL ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results